As for cancer types, there are 4 studies on VEGF-460 and gastric cancer susceptibility, 7 on breast cancer, 4 on prostate cancer, 3 on oral cancer, 3 on colorectal cancer, 2 on colon cancer, 2 on glioma, 3 on cervical cancer, 2 on ovarian cancer, 2 on bladder cancer, 5 on hepatocellular carcinoma, 11 on lung cancer, and 5 on renal cell carcinoma, in addition to studies on endometrial cancer, esophageal adenocarcinoma, pancreatic cancer, nasopharyngeal cancer, osteosarcoma, thyroid cancer, and cutaneous squamous cell carcinoma. Here, VEGFA is linked to lung carcinoma.